Developed by VHIO investigators, the SALSA artificial intelligence (AI)-aided tool (SALSA) works directly on medical images, automatically detecting and delineating tumors.
Read moreALLOX has developed its own proprietary platform that integrates experimental genetics, artificial intelligence, and energy-based models to identify allosteric sites and transform them into novel ther...
Read moreInvestigadores del Cima Universidad de Navarra confirman que esta técnica mejora la predicción de interacciones entre fármacos y proteínas y podría acelerar el desarrollo de tratamientos
Read moreEl Hospital de Bellvitge se ha sumado a uno de los estudios más grandes del mundo sobre inteligencia artificial (IA) aplicada a la prevención del cáncer de colon y recto. Se trata del proyecto ACCE...
Read moreA study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. R...
Read moreThese findings suggest that the IRS1 gene could serve as an early epigenetic marker for identifying children at higher risk of developing metabolic disorders. This could pave the way for much earlier ...
Read moreThe current 21st century will be remembered for the shift from treatment-focused to prevention-focused medicine. Vaccines, screening programmes, predictive genetics and digital health are tools that, ...
Read moreAAVion®, a fully integrated AAV manufacturing platform designed to accelerate gene therapy development. A ready-to-use Plasmid Platform intended to meet the increasing demand for plasmid DNA
Read moreIRB Barcelona researchers have developed a new computational tool that tracks the evolutionary shifts in selection pressure during tumorigenesis and chemotherapy.
Read moreThe Multimodal Imaging Biomarkers research group at IDIBAPS is participating in the European project EUCAIM (EUropean Federation for CAncer IMages), a strategic initiative of the Europe's Beating Canc...
Read moreUn nuevo ensayo clínico integrará inteligencia artificial con nuevos biomarcadores para tratar de predecir mejor el éxito de las terapias contra la tuberculosis
Read moreGENESIS Biomed celebrates its 2025 Annual Symposium with the attendance of more than 110 attendees.
Read more